Benefits of Red Light Therapy: What the Evidence Supports

Red light therapy — also called low-level light therapy, low-level laser therapy or photobiomodulation — uses low levels of red light, and Cleveland Clinic describes it as an emerging treatment promoted for wrinkles, scars, redness and acne, with more clinical trials still needed to confirm effectiveness.

The devices, session logistics and costs are the subject of our red light therapy guide; this page stays on the evidence for each benefit.

The strongest single skin trial in our sources is from 2014.

Wunsch and Matuschka gave 136 volunteers 30 sessions of red light (611–650 nm) or broadband light, twice weekly, and found improved skin complexion, improved roughness and higher ultrasound-measured collagen density compared with controls.

Broadband light showed no advantage over red light alone.

It is one trial with one device's parameters — a result measured in people, but not a promise for any device, course or person.

On acne, the two reviews in our sources read the evidence differently.

A 2018 systematic review of 31 randomized trials of LED devices in dermatology gave its grade B recommendation to acne, herpes simplex and zoster, and acute wound healing, and only grade C or D to other skin conditions, while flagging small samples, missing blinding or sham controls and varied light parameters.

The 2016 Cochrane review of light therapies for acne, including photodynamic therapy — 71 trials, 4,211 participants — rated the evidence on patients' global improvement as very low quality and concluded that high-quality evidence is lacking.

Read together, the reviews say something may be there for acne, and the people who have read the trials most closely do not consider it settled.

On the regulatory side, light-based devices are Class II devices cleared by FDA through the 510(k) process, not approved the way drugs are: product code OHS covers over-the-counter light-based wrinkle reduction and product code OLP covers over-the-counter red and blue light devices for mild-to-moderate acne, both under 21 CFR 878.4810.

A 510(k) clearance covers only the indication in that device's own submission, so a specific device on a med spa's shelf may not hold the clearance its marketing implies.

The hair-growth evidence in our sources is a 2017 meta-analysis of randomized trials (Adil and Godwin, Journal of the American Academy of Dermatology), which found low-level laser light therapy superior to placebo for hair growth in men with androgenetic alopecia — male pattern hair loss.

The same analysis flagged high heterogeneity, meaning the individual trials' results varied widely, so how big the effect is remains unsettled.

Two scope limits matter.

The meta-analysis covered men, and we found no equivalent meta-analysis of low-level laser therapy for women in the sources we checked, so its finding cannot be extended to them.

And the FDA product category here is laser combs for male androgenetic alopecia (product code OAP) — a cleared category, not a statement about any specific comb, because each clearance covers its own device and indication.

Pain has its own cleared device category, but the med spa evidence for it is thin in our sources.

Non-thermal lasers for adjunctive pain therapy are a cleared FDA category under 21 CFR 890.5500 (product code NHN).

Adjunctive means alongside standard treatment — the cleared wording is not a replacement for a pain plan.

Wound healing is not the same as athletic recovery, but the same 2018 LED review that graded acne gave acute wound healing its grade B — one of only three indications to reach it — with the same caveats about small samples and varied light parameters.

The best-supported use of photobiomodulation in our sources is medical rather than cosmetic.

The MASCC/ISOO international guidelines (Zadik et al., 2019) recommend specific photobiomodulation protocols to prevent oral mucositis — the mouth sores caused by cancer treatment — in certain cancer patients, including stem-cell transplant and head-and-neck radiotherapy patients.

That is a protocol for cancer care delivered in a medical setting, not a med spa service.

What we did not find in the sources we checked is controlled trial evidence quantifying how well red light therapy works for pain in a med spa setting.

If a provider sells it for back pain, joint pain or athletic recovery, ask which studies they are relying on.

This is the claim to treat with particular skepticism, and the sources are unusually direct.

Cleveland Clinic states there is no scientific evidence supporting red light therapy for weight loss, cancer, cellulite removal, or mental health conditions such as depression and seasonal affective disorder.

Fat-loss claims fall under the same finding, and we found no support for "detox" claims in our sources either.

Marketing often fills that gap.

If a med spa markets a red light bed for fat loss, a "detox" or cellulite reduction, note the split: Cleveland Clinic's evidence review found no scientific support for cellulite removal, and our research found no support for the fat-loss and "detox" pitches either.

Its statements on depression and seasonal affective disorder sit in the same no-evidence category.

A red light course priced as a weight-loss program is priced around a claim the evidence Cleveland Clinic reviewed does not support.

Part of the gap is study quality.

Cleveland Clinic notes that many published red light studies included only a small number of people, lacked a placebo group, or were conducted in animals or cells rather than humans.

That is why this page leans on the sources that measured outcomes in people — the 2014 skin trial, the 2016 Cochrane review, the 2018 review of randomized trials, the 2017 hair-growth meta-analysis and the 2019 MASCC/ISOO guideline — and treats the rest as marketing until the studies catch up.

The proposed mechanism is also still a proposal.

Cleveland Clinic's explanation is that red light therapy is thought to act on mitochondria, with proposed effects including stimulated collagen and fibroblast production, better circulation and reduced inflammation — proposed mechanisms, not proven outcomes.

The table pulls the grading together. "Strongest evidence" means the best source we found for that benefit — it is not a prediction of anyone's result.

None of this proves red light therapy does nothing; it means that for weight loss, cellulite and the related pitches, no source we checked shows it works, and the benefits with positive findings rest on single trials or reviews that come with caveats.

Those are different positions, and it is worth knowing which one a device's marketing rests on.

Because the benefits grade so differently, the useful provider questions are the ones that tie the pitch to the evidence.

If the goal is skin texture or acne, ask how the device's clearance and the proposed course match the studies above.

If the pitch is hair growth, the data are in men.

If it is weight loss, Cleveland Clinic finds no scientific evidence for it; for "detox," we found no support in our sources.

Practically, Cleveland Clinic says red light therapy usually needs ongoing sessions — typically one to three a week, for weeks or months — and that it is typically not covered by health insurance, so the commitment is real before any result is.

At-home devices are generally safe per Cleveland Clinic, but they may be less powerful than the devices dermatologists and other trained skin professionals use, so results may differ between the two routes.

A licensed provider can tell you where your goal sits on this spectrum and whether a course makes sense for your case.